从监狱释放后获得抗逆转录病毒治疗
Jacques Baillargeon1, Thomas P Giordano, Josiah D Rich
1Department of Preventive Medicine and Community Health, University of Texas Medical Branch, 301 University Blvd, Mail Route 1007, Galveston, TX 77555, USA. jbaillar@utmb.edu
JAMA
|February 27, 2009
概括
在接受艾滋病毒治疗的囚犯中,只有30%的人在释放后60天内完成了初始抗逆转录病毒疗法 (ART) 处方. 这凸显了从监狱转移到社区的HIV阳性患者的关怀中的关键差距.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 医疗保健服务研究 医疗服务研究
背景情况:
- 从监禁中释放后中止抗逆转录病毒疗法 (ART) 可能导致不良健康结果和艾滋病毒传播.
- 了解监狱释放后的ART坚持模式对于防止耐药性HIV储存器至关重要.
- 释放后HIV感染囚犯重新填补ART处方的比例在很大程度上是未知的.
研究的目的:
- 量化获取在释放后60天内获得ART处方的囚犯的百分比.
- 在以前被监禁的个人中确定与ART处方补充相关的预测因素.
主要方法:
- 一项回顾性队列研究分析了2115名从德克萨斯州监狱释放的感染艾滋病毒的囚犯 (2004-2007).
- 在被释放之前,囚犯正在接受ART治疗.
- 评估了处方填充率在发布后的10,30和60天.
主要成果:
- 只有30.0%的囚犯在释放后60天内填写了ART处方.
- 西班牙裔和非裔美国囚犯在10天和30天内填写处方的可能性较低.
- 诸如无法检测到的病毒载量,假释状态和艾滋病药物援助计划 (ADAP) 援助等因素与更高的补充率有关.
结论:
- 很大一部分感染艾滋病毒的囚犯在从监狱释放后不久就没有填写ART处方.
- 需要有针对性的干预措施来改善这一弱势群体的ART连续性.
- 解决差异和提供支持服务可以增强释放后的艾滋病毒护理.
相关概念视频
Retrovirus Life Cycles
43.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.1K
Retroviruses
12.2K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.2K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
420
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
420


